The company will compete with a device Boston Scientific acquired for $850 million.

While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...

Many companies forecast specific tariff charges. Then the White House and China agreed to a 90-day pause in their trade ...

CEO Geoff Martha told investors the split simplifies Medtronic’s portfolio, while creating a stand-alone diabetes tech ...

The Food and Drug Administration has authorized more medical devices that incorporate artificial intelligence. Keep track of ...

A jury found that Biosense Webster withheld services to hospitals using reprocessed catheters.

Teal won FDA approval for a self-collection device after running a study at 16 sites in the U.S. Writing in the JAMA paper, ...

EndoQuest Robotics completed two procedures with its endoluminal system, while Virtuoso Surgical successfully performed ...

Inside the evolving science of sterilization compatibility and why your next packaging decision might improve patient ...

In earnings calls, diabetes tech companies had less to say about tariffs and focused more on future growth.

Dave Rosa, Intuitive Surgical’s president, will take over as chief executive on July 1, as the surgical robot maker accelerates the rollout of its latest da Vinci system.